Acute Graft-versus-Host Disease Market is Driven by Rising Transplants

agregó una foto Health

2025-05-30 07:31:35 -

The acute graft-versus-host disease (GVHD) market encompasses therapeutic products designed to prevent or treat the immune-mediated complications that arise following allogeneic hematopoietic stem cell transplantation (HSCT). Key products include calcineurin inhibitors, corticosteroids, monoclonal antibodies, and emerging cell-based therapies such as mesenchymal stromal cells. Advantages of...

0 Commentarios 0 Acciones 615 Views 0 Vista previa